Valion Bio's total assets for Q2 2026 were $6.23M, a decrease of -80.82% from the previous quarter. VBIO total liabilities were $638.00K for the fiscal quarter, a -96.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.